Once implanted, the sensor wirelessly sends data about biomarkers to an external “reader” device, allowing doctors to better monitor a patient’s progress and adjust or switch therapies.
Image courtesy of the researchers
Biochemical sensor implanted at initial biopsy could allow doctors to better monitor and adjust cancer treatments.
In the battle against cancer, which kills nearly 8 million people worldwide each year, doctors have in their arsenal many powerful weapons, including various forms of chemotherapy and radiation. What they lack, however, is good reconnaissance — a reliable way to obtain real-time data about how well a particular therapy is working for any given patient.
Magnetic resonance imaging and other scanning technologies can indicate the size of a tumor, while the most detailed information about how well a treatment is working comes from pathologists’ examinations of tissue taken in biopsies. Yet these methods offer only snapshots of tumor response, and the invasive nature of biopsies makes them a risky procedure that clinicians try to minimize.
Now, researchers at MIT’s Koch Institute for Integrative Cancer Research are closing that information gap by developing a tiny biochemical sensor that can be implanted in cancerous tissue during the initial biopsy. The sensor then wirelessly sends data about telltale biomarkers to an external “reader” device, allowing doctors to better monitor a patient’s progress and adjust dosages or switch therapies accordingly. Making cancer treatments more targeted and precise would boost their efficacy while reducing patients’ exposure to serious side effects.
“We wanted to make a device that would give us a chemical signal about what’s happening in the tumor,” says Michael Cima, the David H. Koch (1962) Professor in Engineering in the Department of Materials Science and Engineering and a Koch Institute investigator who oversaw the sensor’s development. “Rather than waiting months to see if the tumor is shrinking, you could get an early read to see if you’re moving in the right direction.”
Two MIT doctoral students in Cima’s lab worked with him on the sensor project: Vincent Liu, now a postdoc at MIT, and Christophoros Vassiliou, now a postdoc at the University of California at Berkeley. Their research is featured in a paper in the journal Lab on a Chip that has been published online.
Measurements without MRI
The sensors developed by Cima’s team provide real-time, on-demand data concerning two biomarkers linked to a tumor’s response to treatment: pH and dissolved oxygen.
As Cima explains, when cancerous tissue is under assault from chemotherapy agents, it becomes more acidic. “Many times, you can see the response chemically before you see a tumor actually shrink,” Cima says. In fact, some therapies will trigger an immune system reaction, and the inflammation will make the tumor appear to be growing, even while the therapy is effective.
Oxygen levels, meanwhile, can help doctors gauge the proper dose of a therapy such as radiation, since tumors thrive in low-oxygen (hypoxic) conditions. “It turns out that the more hypoxic the tumor is, the more radiation you need,” Cima says. “So, these sensors, read over time, could let you see how hypoxia was changing in the tumor, so you could adjust the radiation accordingly.”
The sensor housing, made of a biocompatible plastic, is small enough to fit into the tip of a biopsy needle. It contains 10 microliters of chemical contrast agents typically used for magnetic resonance imaging (MRI) and an on-board circuit to communicate with the external reader device.
Devising a power source for these sensors was critical, Cima explains. Four years ago, his team built a similar implantable sensor that could be read by an MRI scanner. “MRI scans are expensive and not easy to make part of routine care,” he says. “We wanted to take the next step and put some electronics on the device so we could take these measurements without an MRI.”
For power, these new sensors rely on the reader. Specifically, there’s a metal coil inside the reader and a much smaller coil in the sensor itself. An electric current magnetizes the coil inside the reader, and that magnetic field creates a voltage in the sensor’s coil when the two coils are close together — a process called mutual inductance. The reader sends out a series of pulses, and the sensor “rings back,” as Cima puts it. The variation in this return signal over time is interpreted by a computer to which the reader is wired, revealing changes in the targeted biomarkers.
Read more: Real-Time Data for Cancer Therapy
The Latest on: Biochemical sensor
via Google News
The Latest on: Biochemical sensor
- Global Biochemical Sensors Market Size and Growth 2022 Analysis Report by Share, Growth Rate, Emerging Trends, and Forecast to 2028on August 3, 2022 at 3:59 am
Global “Biochemical Sensors Market” 2022 report presents a comprehensive study of the entire Global market including market size, share trends, market dynamics, and overview by segmentation by ...
- Spider silk-based fibre optic sensor gets the measure of glucoseon August 3, 2022 at 3:01 am
The light-guiding properties of spider silk have been harnessed to develop a sensor that detects and measures small changes in the refractive index of a biological solution including glucose.
- Researchers create biosensor by turning spider silk into optical fiberon August 2, 2022 at 10:59 am
The new light-based sensor might one day be useful for measuring blood sugar and other biochemical analytes. Researchers have harnessed the light-guiding properties of spider silk to develop a ...
- Researchers create biosensor by turning spider silk into optical fiberon August 2, 2022 at 8:32 am
The new light-based sensor might one day be useful for measuring blood sugar and other biochemical analytes. “Glucose sensors are crucial to people with diabetes, but these devices tend to be ...
- Smart Necklace Biosensor Monitors Glucose Levels Through Sweaton July 25, 2022 at 8:10 am
A device that might one day utilize the chemical indicators in sweat to identify changes in a person’s health has successfully undergone testing by researchers.
- A special necklace measures blood sugar in real timeon July 25, 2022 at 3:27 am
Improved blood glucose monitoring. Now, for the first time, a wearable device using a biochemical sensor capable of monitoring blood sugar has been successfully tested. The smart ...
- Ohio State University: ‘Smart necklace’ biosensor may track health status through sweaton July 23, 2022 at 4:35 am
Researchers have successfully tested a device that may one day use the chemical biomarkers in sweat to detect changes in a person’s health. In a new study published in the journal Science Advances, a ...
- Wireless biochemical sensor may use biomarkers in sweat to detect changes in a person's healthon July 22, 2022 at 9:49 am
In a new study published in the journal Science Advances, a team from The Ohio State University demonstrated a battery-free, wireless biochemical sensor that detected the blood sugar – or ...
- 'Smart necklace' biosensor may track health status through sweaton July 22, 2022 at 7:28 am
Researchers have successfully tested a device that may one day use the chemical biomarkers in sweat to detect changes in a person's health.
via Bing News